Skip to main content
. 2022 Mar 15;149(3):1095–1101. doi: 10.1007/s00432-022-03943-0

Fig. 5.

Fig. 5

Progression-free survival stratified for patients with a single AGM at the time of SBRT versus those with AGM and additional metastases